GSK, Theravance report completion of Relovair studies in COPD and asthma – Pharmaceutical Business Review


Visit Bulgaria

GSK, Theravance report completion of Relovair studies in COPD and asthma
Pharmaceutical Business Review
GlaxoSmithKline (GSK) and Theravance have announced the completion of the phase III registration programme for the once-daily investigational medicine Relovair used to treat chronic obstructive pulmonary disease (COPD) and asthma.
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies MarketWatch (press release)
Theravance Falls Most in 3 Years After Glaxo Drug FailsBusinessWeek
Glaxo on the slide after trials setback for asthma drugEvening Standard
Visit Bulgaria –TheStreet.com –Wall Street Journal (India)
all 64 news articles »

View full post on asthma – Google News

Dynavax and AstraZeneca Agree to Conduct Toxicology Studies for TLR-9 Agonist … – Healthcare Global (press release)

Dynavax and AstraZeneca Agree to Conduct Toxicology Studies for TLR-9 Agonist
Healthcare Global (press release)
These include demonstration that AZD1419 is capable of producing long lasting disease-modifying effects in a mouse model of atopic asthma. Under the terms of the amended 2006 research collaboration and license agreement, AstraZeneca will provide to

View full post on asthma – Google News

Studies suggest an acetaminophen-asthma link – STLtoday.com


Care2.com

Studies suggest an acetaminophen-asthma link
STLtoday.com
The sharp worldwide increase in childhood asthma over the past 30 years has long perplexed researchers, who have considered explanations as varied as improved hygiene and immunizations. Over the last decade, however, a new idea has emerged.
Is Acetaminophen Causing Asthma?Care2.com
Studies indicate acetaminophen link to asthmaSanta Rosa Press Democrat
Study: Acetaminophen Increases Risk of AsthmaFOX 9 News
New York Times (blog) –BabyCenter (blog) –ABC30.com
all 11 news articles »

View full post on asthma – Google News

Dynavax and AstraZeneca Agree to Conduct Toxicology Studies for TLR-9 Agonist … – MarketWatch (press release)

Dynavax and AstraZeneca Agree to Conduct Toxicology Studies for TLR-9 Agonist
MarketWatch (press release)
These include demonstration that AZD1419 is capable of producing long lasting disease-modifying effects in a mouse model of atopic asthma. Under the terms of the amended 2006 research collaboration and license agreement, AstraZeneca will provide to

and more »

View full post on asthma – Google News

Merck Announces Presentation of Phase III Investigational Studies Evaluating … – MarketWatch (press release)

Merck Announces Presentation of Phase III Investigational Studies Evaluating
MarketWatch (press release)
DULERA is indicated in the United States for the treatment of asthma in patients 12 years and older.(1) It is not indicated for the relief of acute bronchospasm or for the treatment of COPD. A supplemental new drug application (sNDA) for DULERA for the

and more »

View full post on asthma – Google News

Studies Link Asthma with Variations in IL6 Receptor Gene and Chromosome 11q13.5 – Genetic Engineering News

Studies Link Asthma with Variations in IL6 Receptor Gene and Chromosome 11q13.5
Genetic Engineering News
Genome-wide association studies focused on asthma risk genes have identified a variation in the interleukin-6 receptor (IL6R), and alterations at another site on chromosome 11q13.5 near the leucine-rich repeat containing 32 gene (LRRC32, also known as

and more »

View full post on asthma – Google News

UH Rainbow Babies and Children’s Hospital opens asthma studies – EurekAlert (press release)

UH Rainbow Babies and Children's Hospital opens asthma studies
EurekAlert (press release)
UH Rainbow, one of the 27 clinical sites in the United States, has partnered with University of Pittsburgh Medical Center (through a subcontract with Case Western Reserve University), to collaborate on these studies and future asthma clinical research

and more »

View full post on asthma – Google News